Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diagon is a prominent global developer and manufacturer of in vitro diagnostic (IVD) solutions, with a core focus on hematology and coagulation. Established in 1989 and headquartered in Budapest, Hungary, the company has grown into a significant international player, exporting products to more than 100 countries. Diagon is particularly well-known for its extensive portfolio of high-quality reagents that are compatible with various third-party automated analyzers, as well as its own proprietary line of diagnostic instruments. Their product range includes the Coag XL automated coagulation analyzer and the D-Cell series of hematology systems. The company operates multiple manufacturing facilities globally, ensuring compliance with international quality standards such as ISO 13485. Diagon continues to invest in research and development to expand its diagnostic capabilities in clinical chemistry and specialized testing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diagon.